https://manufacturingchemist.com/txcell-signs-inlicensing-agreement-with-inserm-transfert-for-novel-population-of-regulatory-t-cells-123737
TxCell Signs inlicensing agreement with Inserm Transfert for novel population of regulatory T cells
TxCell SA, a biotechnology company developing innovative, personalised cellular immunotherapies using regulatory T cells (Treg) to treat severe chronic...